Underlying Health Conditions, Turner Syndrome, and the COVID-19 Virus

​

Are people with Turner syndrome (TS) at a higher risk of contracting the COVID-19 virus? This is a question we're receiving from many members of our community. We're providing this information to help people with TS determine if they have an underlying TS-related health condition that makes them more vulnerable to serious complications of COVID-19.

​

CDC Guidance as of August 23, 2024

 

Recommendations for

2024–2025 Moderna COVID-19 Vaccine and 2024–2025 Pfizer-BioNTech COVID-19 Vaccine

​

People who are not moderately or severely immunocompromised

Initial vaccination

• Ages 6 months–4 years

  • 2 doses of 2024–­2025 Moderna or 3 doses of 2024–­2025 Pfizer-BioNTech

• Ages 5 years and older

  • 1 dose of 2024–2025 Moderna or 1 dose of 2024–2025 Pfizer-BioNTech

Received previous doses of a COVID-19 vaccine

• Ages 6 months–4 years

  • 1 or 2 doses of 2024–­2025 mRNA vaccine from the same manufacturer as administered for initial vaccination, depending on the vaccine and the number of prior doses

• Ages 5 years and older

  • 1 dose of 2024–­2025 Moderna or 1 dose of 2024–­2025 Pfizer-BioNTech

Additional dose: An additional dose of 2024–­2025 COVID-19 vaccine for people ages 65 years and older who are not moderately or severely immunocompromised is NOT currently recommended.

​

People who are moderately or severely immunocompromised

Initial vaccination

• Ages 6 months and older

  • 3 doses of 2024–­2025 Moderna or 3 doses of 2024–­2025 Pfizer-BioNTech

Received previous doses of a COVID-19 vaccine

• Recommended mRNA vaccine and number of 2024–­2025 doses are based on age and vaccination history

Additional doses: People who are moderately or severely immunocompromised ages 6 months and older may receive 1 or more age-appropriate doses of a 2024–2025 mRNA COVID-19 vaccine.